ReviewHepatology communications2026
Neutrophil extracellular traps: A central player in liver diseases.
Review in Hepatology communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neutrophil extracellular traps (NETs) are known for their propensity to expel decondensed chromatin embedded with inflammatory proteins, which can entrap and kill pathogens. The destructive role of NETs in sterile liver inflammation has also been elucidated. Therefore, NETs appear to have both beneficial and pathogenic roles for varying diseases of the liver. In this review, we discuss recent findings related to NETs in inflammatory and fibrotic liver diseases as well as liver cancer. We provide a comprehensive overview of the underlying factors contributing to NET formation within the hepatic microenvironment, encompassing diverse pathological contexts. Moreover, we shed light on the multifaceted involvement of NETs in processes such as liver inflammation, fibrosis, and premalignant conditions. We also provide insights into the roles of NETs in providing a tumor-feeding niche for HCC survival and liver metastasis of other cancers. Finally, we will discuss potential therapies targeting NETs for future application in liver diseases. By reviewing these intricate interactions, we aim to enhance our understanding of the complex role played by NETs in hepatic pathophysiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.